Published in
Wiley, Pharmacoepidemiology & Drug Safety, 11(26), p. 1357-1366
DOI: 10.1002/pds.4293
Links
Tools
Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes
Journal article published in 2017 by
Prasad L. Gawade 
,
Jesse A. Berlin,
David H. Henry,
Dianne Tomita,
Barry D. Brooks,
Janet Franklin,
Brian D. Bradbury,
Cathy W. Critchlow
,
Jesse A. Berlin,
David H. Henry,
Dianne Tomita,
Barry D. Brooks,
Janet Franklin,
Brian D. Bradbury,
Cathy W. Critchlow
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 